PEDRO RUIZ AWARD
This award is intended to honor and perpetuate the memory of Pedro Ruiz (RIP), the founding president of the WADD and his work for the benefit of the WADD, the dissemination of the concept of Dual Disorders and his contribution to the improvement of the quality of life of patients and their families.
1st Pedro Ruiz Award on Dual Disorders
Aimed at exceptional professionals, exponents of the best contributions to Dual Disorders throughout their careers
1st ANNUAL PEDRO RUIZ AWARD 2024: MIGUEL CASAS
Director “SJD MIND Escoles” Program of the Hospital Sant Joan de Déu of Barcelona. Honorary Professor of Psychiatry at the Universidad Autónoma de Barcelona. Member of the Public Health Advisory Council of the Department de Salut of the Generalitat of Catalunya. President of the Fundació d’Investigació Sant Pau (FISP) Barcelona. Honorary President of Sociedad Española de Patología Dual. Honorary Academician of the “Reial Acadèmia de Medicina” of the Valencian Community. Member of the Editorial Board of various journals in the field of Psychiatry and Addictions. He has received diverse institutional awards and recognitions.
398 articles published with Impact Factor: 1,335.312; H Factor: 59; i10 Index: 326. Number of citations: 17.821. Editor of 34 books on psychiatric topics.
Miquel Casas is developing his professional work in Adolescent and Adult psychiatry over 35 years, focusing his research on the Neurodevelopmental Disorders (ADHD along life span, Dyslexia, etc.) and Borderline Personality Disorders inducing vulnerability for academic failure, behavioural problems, addictions, traffic accidents, violence and criminality, etc. He is also involved in e- Health and m-Health projects in Barcelona.
1st EXTRAORDINARY PEDRO RUIZ AWARD 2024: NORA VOLKOW
Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world’s largest funder of scientific research on the health aspects of drug use and addiction.
Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction.
Dr. Volkow has published almost a thousand peer-reviewed articles, written 113 book chapters, manuscripts and articles, co-edited «Neuroscience in the 21st Century» and edited four books on neuroscience and brain imaging for mental and substance use disorders.
She received a Nathan Davis Award for Outstanding Government Service, was a Samuel J. Heyman Service to America Medal (Sammies) finalist and is a member of the National Academy of Medicine and the Association of American Physicians.
